Peripheral blood mononuclear cell therapy in PAD patients with intermittent claudication randamized trial
Phase 2
- Conditions
- ASO/Buerger disease
- Registration Number
- JPRN-C000000330
- Lead Sponsor
- Department of Cardiovascular Science and Medicine, Chiba University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with malignant diseases, severe diabetic retinopathy, or severe renal failure.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Maximum walking distance, Pain-free walking distance, Recovery time of lower leg BP after exercise, ABPI at 6 months after treatment as compared with those before treatment
- Secondary Outcome Measures
Name Time Method aser doppler image, Scintigraphy, MRI, Angiography, QOL estimation